[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
December 4, 1937

AMENORRHEA: ITS CAUSATION AND TREATMENT

Author Affiliations

NEW YORK

Dr. Salmon is Hiram Vineberg Research Fellow.

From the Gynecological Service and the Laboratories of the Mount Sinai Hospital.

JAMA. 1937;109(23):1863-1869. doi:10.1001/jama.1937.02780490001001
Abstract

This investigation of patients with amenorrhea is a continuation of our studies on oligomenorrhea, amenorrhea and sterility begun in 1931.1 Since our last publications the methods for determining the gonadotropic factors in both blood and urine have been improved.2 As far as treatment is concerned, pure estrogenic substances are now available in large dosage. In addition to gonadotropic substances from pregnancy urine or the placenta, which lack some of the properties of the adenohypophysis, physiologically potent gland preparations and their equivalent—the serum of pregnant mares—are now available. This permits a better evaluation of any prepituitary effects that might be obtained in our carefully controlled series of cases.

MATERIAL  The patients selected had suffered with amenorrhea for various periods and were of various ages. Intelligence, faithful carrying out of orders, ability and willingness to report as directed were of importance in the choice. In one instance the investigation covered

First Page Preview View Large
First page PDF preview
First page PDF preview
×